Home
Conditions
Kidney Neoplasms

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies

Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)

NCT00569946

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: National Cancer Center East Hospital Kashiwa, Chiba, Japan

Hokkaido University Hospital Sapporo, Hokkaido, Japan

Tsukuba University Hospital Tsukuba, Ibaraki, Japan

Iwate Medical University Morioka, Iwate, Japan

View all 18 locations

View Trial Details

Completed

Thermal Ablation in Larger Liver and Kidney Tumours

NCT01720706

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +26 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

E-MOSAIC Electronic Tool to Monitor Symptoms

NCT00477919

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +115 more
Locations: Universitaetsspital-Basel Basel, Switzerland

Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland

Inselspital Bern Bern, Switzerland

Spital Buelach Bülach, Switzerland

View Trial Details

Completed

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery

NCT03064308

Conditions: Abdominal Hysterectomy (& Wertheim), Adenocarcinoma, Behavior, +52 more
Locations: Division of Graduate Entry Medicine and Health, School of Medicine, University of Nottingham. Royal Derby Hospital, Derby, Derbyshire, United Kingdom

View Trial Details

Completed

89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE

NCT03556046

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Radboud University Nijmegen, Netherlands

View Trial Details

Completed

Evaluation of a Laparoscopic High Intensity Focused Ultrasound Probe for the Ablation of Small Renal Masses

NCT02248389

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: IU Health University Hospital Indianapolis, Indiana, United States

View Trial Details

Completed

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

NCT02454478

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Eisai Trial Site #1 Chiba, Japan

Eisai Trial Site #1 Tokyo, Japan

Eisai Trial Site #2 Tokyo, Japan

View Trial Details

Completed

Study To Assess Long Term Safety Of Pazopanib

NCT00387205

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Novartis Investigative Site Duarte, California, United States

Novartis Investigative Site Santa Monica, California, United States

Novartis Investigative Site Aurora, Colorado, United States

Novartis Investigative Site Indianapolis, Indiana, United States

View all 19 locations

View Trial Details

Completed

A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

NCT01136733

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Tucson, Arizona, United States

Orange, California, United States

San Diego, California, United States

Tampa, Florida, United States

View all 37 locations

View Trial Details

Completed

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

NCT01588678

Conditions: Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +23 more
Locations: South Texas Accelerated Research Therapeutics San Antonio, Texas, United States

View Trial Details

Kidney Neoplasms

Kidney Neoplasms trial results

Related conditions